GlobeNewswire Inc.··Renovorx, Inc.RenovoRx Lands Fast Company's Top 10 Innovative Medical Device Firms Amid RenovoCath Momentum
RenovoRx ($RNXT) earns Fast Company recognition as #10 innovative medical device firm, with $1.1M RenovoCath sales and Phase III pancreatic cancer trial advancing toward mid-2026 enrollment completion.
RNXTtargeted oncologyPhase III trial